FDA Inspection 1024608 — Sanford Reproductive Medicine
The FDA completed an inspection of Sanford Reproductive Medicine on August 14, 2017 in Fargo, ND. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 14, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Fargo, ND (United States)